Volume 7: Issue 2
Manufacturer's Immunity: The FDA Compliance Defense
Lars Noah: Thank you for inviting me to participate. I have been intrigued by these issues since writing a seminar paper on this as a student in law school. And they really do continue to attract my attention. I am going to spend my limited time today trying to fl esh out some of the more technical issues, if you will, having to do with the interplay between the Michigan statute and federal preemption arguments, because they are terribly important in terms of how those two avenues are going to operate in practice....